Please use this identifier to cite or link to this item:
https://hdl.handle.net/11000/39360Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wikman-Jorgensen, Philip Erick | - |
| dc.contributor.author | Ibarra, José María | - |
| dc.contributor.author | Devesa, Carlos | - |
| dc.contributor.author | Peris-García, Juan Jorge | - |
| dc.contributor.author | Llenas-García, Jara | - |
| dc.contributor.other | Departamentos de la UMH::Medicina Clínica | es_ES |
| dc.date.accessioned | 2026-02-19T18:39:58Z | - |
| dc.date.available | 2026-02-19T18:39:58Z | - |
| dc.date.created | 2023-12 | - |
| dc.identifier.citation | European Journal of Internal Medicine, Vol. 118 (2023) p.133-135 | es_ES |
| dc.identifier.issn | 0953-6205 | - |
| dc.identifier.uri | https://hdl.handle.net/11000/39360 | - |
| dc.format | application/pdf | es_ES |
| dc.format.extent | 3 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.rights | info:eu-repo/semantics/closedAccess | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | COVID-19 | es_ES |
| dc.subject | nirmatrelvir | es_ES |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es_ES |
| dc.title | Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to moderate COVID-19 in a European health system | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | 10.1016/j.ejim.2023.09.025 | es_ES |
Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to.pdf
1,01 MB
Adobe PDF
Share:
.png)
